Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

NCT06378047 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Locally Advanced Pancreatic Cancer

Interventions

DRUG: Pembrolizumab
DEVICE: Irreversible Electroporation

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]